Dudediligence.

Anteris Technologies Global Corp

AVRNASDAQ · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

97.4M

on 2026-06-30, from 35.9M on 2024-12-31 10-Q ↗

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-07-01. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

$250.0M

TD Securities (USA), agreement of 2026-05-22. No at-the-market sales statement read from a 10-Q or 10-K. 424B3 ↗

Warrants

The 10-Q filed 2026-08-11 is not read yet.

Cash

11.6 quarters

$249.9M on 2026-06-30 ÷ $21.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-01-20Public offeringnot read$5.75$200.0M424B5 ↗
2026-01-20Private placementnot readnot read$320.0M8-K ↗
2025-10-24Private placement2,244,896$4.90not stated8-K ↗
2025-10-24Private placement2,346,936not read$11.5M8-K ↗